Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

Completed

• Conditions: Reverse Total Shoulder Arthroplasty
• Interventions: Procedure: Reverse Total Shoulder Arthroplasty (RTSA)

• Registration Number: NCT04807322
• Lead Sponsor: Bürgerspital Solothurn

Brief Summary

Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.

Detailed Description

This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).

Study Timeline

• Study Start: 2019-03-24
• Primary Completion: 2020-08-04
• Study Completion: 2020-12-21
• Status Verified: 2021-03
• Study First Submitted: 2021-03-16
• Study First Submitted QC: 2021-03-17
• Last Update Submitted: 2021-03-17
• Study First Posted: 2021-03-19
• Last Update Posted: 2021-03-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Patients older than 83 years at time of surgery
• Patients who received a reverse total shoulder arthroplasty

Exclusion Criteria

• Patients younger than 83 years at time of surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Elective cases	Reverse Total Shoulder Arthroplasty (RTSA)	Patients, who received a RTSA for degenerative reasons like cuff arthropathy or osteoarthritis
Fracture cases	Reverse Total Shoulder Arthroplasty (RTSA)	Patients, who received a RTSA for a proximal humerus fracture

Primary Outcome Measures

Name	Time	Method
Mortality	until august 2020	Survivership
Quality adjusted life year (QALY)	until august 2020	The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.
Patient reported outcome score: ASES	until august 2020	American Shoulder and Elbow Society (ASES) Score
Patient reported outcome score: VAS	until august 2020	Visual analog score (VAS)
Patient reported outcome score: QuickDASH	until august 2020	Quick Disabilities of the arm, shoulder and hand (DASH) Score,
Complication rate	until august 2020	postoperative complications requiring surgical intervention

Secondary Outcome Measures

Name	Time	Method
Patient demographics	at time of surgery	male/female ratio, age, BMI, ASA (American Society of Anesthesiologists) classification, hospital stay length, range of motion

Trial Locations

Locations (1)

Bürgerspital Solothurn; 🇨🇭 Solothurn, Switzerland